Just trying to see if anyone has any objective information that would see the risk in this biotech worthwhile.
My maths is simple: at $1 per share PRR will have a market cap of over $1,000,000,000.
In all seriousness, how can PRR be worth that much? - only objective responses will be responded to.
$1 billion market cap at $1 per share....
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 510 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 32000 | 1 |
View Market Depth
| Last trade - 09.43am 08/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable